Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VVZ-149 PCA for Post-Operative Pain in Laparoscopic Colectomy
NCT07821307Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Jul 2025
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 2 trial of opiranserin, sponsored by Samsung Medical Center. Started Jul 2025; status: completed.
02
Drugs
opiranserin
Beyond the preview
Go deeper on NCT07821307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07821307.